293 filings
Page 8 of 15
SC 13G/A
TRDA
Entrada Therapeutics Inc
14 Feb 23
Entrada Therapeutics / PRICE T ROWE ASSOCIATES ownership change
12:00am
8-K
TRDA
Entrada Therapeutics Inc
9 Feb 23
Regulation FD Disclosure
7:06am
SC 13G/A
TRDA
Entrada Therapeutics Inc
6 Feb 23
Entrada Therapeutics / WELLINGTON MANAGEMENT ownership change
2:51pm
4
TRDA
Entrada Therapeutics Inc
30 Jan 23
Entrada Therapeutics / Dipal Doshi ownership change
4:32pm
4
TRDA
Entrada Therapeutics Inc
10 Jan 23
Entrada Therapeutics / Dipal Doshi ownership change
4:40pm
8-K
TRDA
Entrada Therapeutics Inc
9 Jan 23
Other Events
7:06am
4
Nerissa Kreher
3 Jan 23
Entrada Therapeutics / NERISSA KREHER ownership change
4:32pm
4
Dipal Doshi
29 Dec 22
Entrada Therapeutics / Dipal Doshi ownership change
4:51pm
8-K
TRDA
Entrada Therapeutics Inc
19 Dec 22
Entrada Therapeutics Announces Clinical Hold on IND Application for ENTR-601-44 in Duchenne Muscular Dystrophy
4:38pm
4
Kory James Wentworth
12 Dec 22
Entrada Therapeutics / KORY JAMES WENTWORTH ownership change
4:36pm
8-K
TRDA
Entrada Therapeutics Inc
8 Dec 22
Entry into a Material Definitive Agreement
7:09am
4
Kory James Wentworth
6 Dec 22
Entrada Therapeutics / KORY JAMES WENTWORTH ownership change
5:02pm
4
TRDA
Entrada Therapeutics Inc
30 Nov 22
Entrada Therapeutics / Dipal Doshi ownership change
4:31pm
4
Kory James Wentworth
18 Nov 22
Entrada Therapeutics / KORY JAMES WENTWORTH ownership change
4:59pm
EFFECT
TRDA
Entrada Therapeutics Inc
8 Nov 22
Notice of effectiveness
12:15am
10-Q
2022 Q3
TRDA
Entrada Therapeutics Inc
Quarterly report
7 Nov 22
7:39am
8-K
TRDA
Entrada Therapeutics Inc
7 Nov 22
Entrada Therapeutics Reports Third Quarter 2022 Financial Results
7:24am
CORRESP
TRDA
Entrada Therapeutics Inc
4 Nov 22
Correspondence with SEC
12:00am
UPLOAD
TRDA
Entrada Therapeutics Inc
3 Nov 22
Letter from SEC
12:00am
4
TRDA
Entrada Therapeutics Inc
2 Nov 22
Entrada Therapeutics / Nathan J Dowden ownership change
4:54pm